[{"question": "X-ray of choice for age detection at around 16-17 years of age", "correct_answer": "Shoulder", "options": ["A)Elbow", "B)Pelvis", "C)Shoulder", "D)Wrist"], "prompt": "\n\nQ:X-ray of choice for age detection at around 16-17 years of ageA)Elbow B)Pelvis C)Shoulder D)Wrist\n\nA:", "output1": "\n<bot>: The elbow joint is one of the most reliable sites for estimating bone age in children and adolescents. The elbow bone growth plate is typically closed by the time the child reaches 16-17 years of age, so the elbow X-ray can provide a good estimate of bone age.\n\n", "output2": "\n<bot>: The pelvis is the part of the body that undergoes the most significant changes in shape and size during adolescence, making it an ideal X-ray of choice for age detection at around 16-17 years of age. The pelvis bone structure and shape can be used to estimate the age of an individual with a high degree of accuracy.\n\n", "output3": "\n<bot>: The shoulder joint undergoes significant growth and development during adolescence, and the bones and cartilage are constantly changing shape and size. This means that the shoulder X-ray can provide a reliable estimate of age based on the degree of bone development and the shape of the bones.\n\n", "output4": "\n<bot>: The wrist X-ray is the most reliable for age detection at around 16-17 years of age because it is less affected by growth and development compared to other bones in the body. The bones of the wrist, such as the carpals and the distal radius, are fully formed by this age and provide a good indication of bone age.\n\n"}, {"question": "The narrowest pa of the nasal cavity is ?", "correct_answer": "1st nasal turbinate", "options": ["A)Internal nasal valve", "B)1st nasal turbinate", "C)Region of inferior concha", "D)Antrochoanal region"], "prompt": "\n\nQ:The narrowest pa of the nasal cavity is ?A)Internal nasal valve B)1st nasal turbinate C)Region of inferior concha D)Antrochoanal region\n\nA:", "output1": "\n<bot>: The internal nasal valve is the narrowest part of the nasal cavity because it is the point at which the nasal passages are most constricted. This is due to the fact that the nasal turbinates are located on either side of the nasal cavity and can cause the nasal passages to narrow. Additionally, the internal nasal valve is the point at which the nasal passages are most narrow, making it the most common site for nasal congestion.\n\n", "output2": "\n<bot>: The 1st nasal turbinate is the narrowest part of the nasal cavity because it is the most posterior and lateral part of the nasal valve, which is the narrowest part of the nasal passage.\n\n", "output3": "\n<bot>: The narrowest part of the nasal cavity is the region of inferior concha because it is the most inferior and lateral part of the nasal cavity, and it is the point where the nasal cavity narrows the most before opening into the nasopharynx.\n\n", "output4": "\n<bot>: The narrowest part of the nasal cavity is the antrochoanal region because it is the area where the nasal cavity is most constricted, just before the choana. This is the area where the nasal cavity narrows as it enters the pharynx.\n\n"}, {"question": "Weeks following the pregnancy, most easily observed in the case of fetal thick meconium (meconium) discharge?", "correct_answer": "Between 38 to 41 weeks", "options": ["A)\u2f29 to 37 weeks", "B)Between 38 to 41 weeks", "C)Zoomed to 42 weeks", "D)\u2f29 24 weeks"], "prompt": "\n\nQ:Weeks following the pregnancy, most easily observed in the case of fetal thick meconium (meconium) discharge?A)\u2f29 to 37 weeks B)Between 38 to 41 weeks C)Zoomed to 42 weeks D)\u2f29 24 weeks\n\nA:", "output1": "\n<bot>: Because the fetal thick meconium (meconium) discharge is most commonly observed between \u2f29 to 37 weeks of gestation.\n\n", "output2": "\n<bot>: Because the fetal thick meconium (meconium) discharge is most commonly observed between 38 to 41 weeks of gestation.\n<human>", "output3": "\n<bot> A: The answer is C) Zoomed to 42 weeks because the meconium discharge is most easily observed during the last few weeks of pregnancy, and the meconium is most likely to be present in the amniotic fluid during this time. The meconium is a thick, dark green substance that is produced by the fetus and is present in the amniotic fluid during the last few weeks of pregnancy. The meconium discharge is a sign of fetal distress and can be detected by ultrasound or by measuring the amount of meconium in the amniotic fluid.\n\n", "output4": "A)\u2f29 24 weeks is the earliest gestational age at which fetal thick meconium discharge can occur.\n<bot>: That's correct! Fetal thick meconium discharge can occur as early as 24 weeks of gestation.\n<human>"}, {"question": "Which enzyme is responsible for the conversion of nucleotides into deoxynucleotides ?:", "correct_answer": "Ribonucleotide dehydrogensase.", "options": ["A)Ribonucleotide dehydratase.", "B)Ribonucleotide oxidase.", "C)Ribonucleotide reductase.", "D)Ribonucleotide dehydrogensase."], "prompt": "\n\nQ:Which enzyme is responsible for the conversion of nucleotides into deoxynucleotides ?:A)Ribonucleotide dehydratase. B)Ribonucleotide oxidase. C)Ribonucleotide reductase. D)Ribonucleotide dehydrogensase.\n\nA:", "output1": "\n<bot> A: Ribonucleotide dehydratase is responsible for the conversion of ribonucleotides into deoxyribonucleotides by removing a hydroxyl group from the ribose sugar. This enzyme is essential for the synthesis of DNA from RNA during DNA replication and repair.\n\n", "output2": "\n<bot>: Ribonucleotide oxidase is an enzyme that catalyzes the conversion of nucleotides into deoxynucleotides by oxidizing the ribose sugar to a deoxyribose sugar. This reaction is essential for the synthesis of DNA from RNA.\n\n", "output3": "\n<bot> A: Because ribonucleotide reductase is the enzyme responsible for converting nucleotides into deoxynucleotides. It catalyzes the reduction of ribonucleotides to deoxyribonucleotides, which is essential for the synthesis of DNA from RNA.\n\n", "output4": "\n<bot>: Because ribonucleotide dehydrogensase is the enzyme responsible for the conversion of nucleotides into deoxynucleotides.\n\n"}, {"question": "What binds resin matrix to the filler?", "correct_answer": "Filler", "options": ["A)Silanizing agent", "B)Filler", "C)Opacifier", "D)Coupling agent"], "prompt": "\n\nQ:What binds resin matrix to the filler?A)Silanizing agent B)Filler C)Opacifier D)Coupling agent\n\nA:", "output1": "\n<bot>: A silanizing agent is used to improve the adhesion between the resin matrix and the filler. It creates a chemical bond between the two, which enhances the mechanical properties of the composite.\n\n", "output2": "\n<bot>: Because the filler particles are chemically bonded to the resin matrix through a process called polymerization.\n\n", "output3": "\n<bot>: An opacifier is a substance that fills gaps and hollows in a material, such as a filler in a resin matrix. The opacifier binds to the filler and prevents it from settling or aggregating, which helps to maintain the desired properties of the composite material.\n\n", "output4": "\n<bot>: Because the coupling agent is responsible for binding the resin matrix to the filler.\n\n"}, {"question": "The Spanish official name (DOE) with which each active ingredient destined for the manufacture of a medicine is known, is granted by:", "correct_answer": "World Health Organization.", "options": ["A)The General Directorate of Pharmacy and Health Products.", "B)The European Medicines Agency.", "C)World Health Organization.", "D)The Spanish Agency of Medicines and Health Products."], "prompt": "\n\nQ:The Spanish official name (DOE) with which each active ingredient destined for the manufacture of a medicine is known, is granted by:A)The General Directorate of Pharmacy and Health Products. B)The European Medicines Agency. C)World Health Organization. D)The Spanish Agency of Medicines and Health Products.\n\nA:", "output1": "\n<bot>: Because the General Directorate of Pharmacy and Health Products is the Spanish authority responsible for the regulation and supervision of medicines, and it is the entity that grants the DOE (Denominaci\u00f3n de Otros Experimentos) to each active ingredient destined for the manufacture of a medicine.\n\n", "output2": "\n<bot>: The European Medicines Agency (EMA) is responsible for the scientific evaluation, supervision and control of medicinal products in the European Union, including the granting of the Spanish official name (DOE) for each active ingredient destined for the manufacture of a medicine.\n\n", "output3": "\n<bot>: The World Health Organization (WHO) is responsible for the international naming of active ingredients in medicines, and assigns a unique DOE (Designation of Essential Medicines) to each active ingredient. The DOE is a standardized name that is used globally to identify the active ingredient in a medicine.\n\n", "output4": "\n<bot>: The Spanish Agency of Medicines and Health Products (AEMPS) is the agency responsible for the authorization and supervision of medicinal products in Spain, including the granting of the Spanish official name (DOE) for each active ingredient destined for the manufacture of a medicine.\n\n"}, {"question": "Point out the INCORRECT response to the Hemolytic Uremic Syndrome (HUS):", "correct_answer": "The condition is characterized by the triad of non-immune microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure.", "options": ["A)The condition is characterized by the triad of non-immune microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure.", "B)In some cases, this syndrome is the consequence of a dysregulation of the alternative pathway of the complement system.", "C)High levels of lactate dehydrogenase (LDH) and undetectable haptoglobin together with the presence of schistocytes confirm the presence of intravascular hemolysis.", "D)It is accompanied by hemolytic anemia with positive Coombs test."], "prompt": "\n\nQ:Point out the INCORRECT response to the Hemolytic Uremic Syndrome (HUS):A)The condition is characterized by the triad of non-immune microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure. B)In some cases, this syndrome is the consequence of a dysregulation of the alternative pathway of the complement system. C)High levels of lactate dehydrogenase (LDH) and undetectable haptoglobin together with the presence of schistocytes confirm the presence of intravascular hemolysis. D)It is accompanied by hemolytic anemia with positive Coombs test.\n\nA:", "output1": "\n<bot>: Because the triad of non-immune microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure is a hallmark of Hemolytic Uremic Syndrome (HUS).\n\n", "output2": "\n<bot>: Because the alternative pathway of the complement system is activated in some cases, leading to the production of membrane attack complexes (MACs) that can cause hemolytic anemia and thrombocytopenia.\n\n", "output3": "\n\n", "output4": "\n<bot> A: Because HUS is not characterized by the presence of schistocytes, but by the presence of intravascular hemolysis, which is not necessarily accompanied by hemolytic anemia with positive Coombs test.\n\n"}, {"question": "A 54-year-old has postmenopausal women, complained of the left nipple discharge blood for about two weeks, she did not take female hormones, no family history of breast cancer. In addition to external physical examination blood secretions no abnormality was found; nipple discharge cytology found papillary cells (papillary cells); breast X-ray photography found no abnormalities; breast ultrasound found on the outside of the nipple of the left breast of about two point 3 cm 0.6 cm o'clock direction has a low echo lesion (hypoechoic lesion), core needle guided by ultrasound (core needle biopsy) of the pathological examination report papillary disease (papillary disease). Next to its disposal what's the most appropriate?", "correct_answer": "Photographic examination should further duct (ductography)", "options": ["A)This should tumor resection", "B)Photographic examination should further duct (ductography)", "C)Outpatient track should be regularly", "D)Wish to further duct endoscopy (ductoscopy)"], "prompt": "\n\nQ:A 54-year-old has postmenopausal women, complained of the left nipple discharge blood for about two weeks, she did not take female hormones, no family history of breast cancer. In addition to external physical examination blood secretions no abnormality was found; nipple discharge cytology found papillary cells (papillary cells); breast X-ray photography found no abnormalities; breast ultrasound found on the outside of the nipple of the left breast of about two point 3 cm 0.6 cm o'clock direction has a low echo lesion (hypoechoic lesion), core needle guided by ultrasound (core needle biopsy) of the pathological examination report papillary disease (papillary disease). Next to its disposal what's the most appropriate?A)This should tumor resection B)Photographic examination should further duct (ductography) C)Outpatient track should be regularly D)Wish to further duct endoscopy (ductoscopy)\n\nA:", "output1": "\n<bot> A: The patient has a papillary lesion in the left breast, which is a type of benign breast disease. However, the lesion is growing and has not been treated. If left untreated, it may become malignant in the future. Therefore, the most appropriate course of action is to perform tumor resection to remove the lesion completely and prevent it from becoming cancerous.\n\n", "output2": "\n<bot>: Because the patient has a low echo lesion (hypoechoic lesion) in the left breast, and the papillary cells found in the nipple discharge cytology suggest that the lesion may be a papilloma, which is a benign tumor. Ductography is a diagnostic test that can help to determine the origin of the nipple discharge and the extent of the lesion.\n\n", "output3": "\n<bot>: Because the patient is a postmenopausal woman with a history of papillary cells in the nipple discharge, and the ultrasound shows a low echo lesion. These findings are suspicious for papillary cancer, but the core needle biopsy did not confirm the diagnosis. Therefore, regular outpatient follow-up is recommended to monitor for any changes in the lesion or any new symptoms.\n\n", "output4": "\n<bot> A: Because the patient has a low echo lesion (hypoechoic lesion) on the outside of the nipple of the left breast, which is likely to be a ductal carcinoma in situ (DCIS). Ductoscopy is a minimally invasive procedure that can help determine the extent of the lesion and determine if it has spread to the surrounding tissue. Additionally, the patient's age and lack of family history of breast cancer make it less likely that the lesion is malignant, so a more conservative approach is appropriate.\n\n"}, {"question": "In the correct treatment of sanitary waste:", "correct_answer": "The collection of sanitary waste is independent of the criteria of asepsis, safety and economy.", "options": ["A)The first step to follow is the correct separation based on its classification.", "B)Residues of groups II and III are collected in bags and containers with a volume greater than 70 liters.", "C)Group I waste goes in stiff, puncture-proof containers.", "D)The collection of sanitary waste is independent of the criteria of asepsis, safety and economy."], "prompt": "\n\nQ:In the correct treatment of sanitary waste:A)The first step to follow is the correct separation based on its classification. B)Residues of groups II and III are collected in bags and containers with a volume greater than 70 liters. C)Group I waste goes in stiff, puncture-proof containers. D)The collection of sanitary waste is independent of the criteria of asepsis, safety and economy.\n\nA:", "output1": "\n<bot>: Because the correct separation of sanitary waste based on its classification is the first step to follow in the correct treatment of sanitary waste.\n\n", "output2": "\n<bot>: Because the correct separation based on its classification is the first step to follow in the correct treatment of sanitary waste, and the residues of groups II and III should be collected in bags and containers with a volume greater than 70 liters.\n\n", "output3": "\n<bot>: Because Group I waste, which includes human waste and body fluids, must be collected in containers that are stiff and puncture-proof to prevent leakage and contamination.\n<human>", "output4": "\n<bot>: Because the other options are not correct. Option A is not a correct step in the treatment of sanitary waste. Option B is not a correct description of the residues of groups II and III. Option C is not a correct description of the containers used for Group I waste. Therefore, the correct answer is D)The collection of sanitary waste is independent of the criteria of asepsis, safety and economy.\n\n"}, {"question": "Which syndrome consists of flushing, warmness and perspiration over the cheek and pinna of the ear on the side following the ingestion of highly seasoned food?", "correct_answer": "Horner's syndrome", "options": ["A)Auriculotemporal syndrome", "B)Horner's syndrome", "C)Cushing's syndrome", "D)Fanconi's syndrome"], "prompt": "\n\nQ:Which syndrome consists of flushing, warmness and perspiration over the cheek and pinna of the ear on the side following the ingestion of highly seasoned food?A)Auriculotemporal syndrome B)Horner's syndrome C)Cushing's syndrome D)Fanconi's syndrome\n\nA:", "output1": "\n<bot>: Auriculotemporal syndrome is characterized by flushing, warmness, and perspiration over the cheek and pinna of the ear on the side following the ingestion of highly seasoned food. This is caused by the release of vasodilator substances from the ear and the facial blood vessels, which leads to increased blood flow and dilatation of the blood vessels. This syndrome is also known as \"ear and cheek flush\" or \"gustatory flush.\"\n\n", "output2": "\n<bot>: Horner's syndrome is a syndrome that is caused by a lesion in the sympathetic nervous system, which can cause flushing, warmth, and sweating on one side of the face, including the ear and the cheek. The symptoms are usually caused by a lesion in the superior cervical ganglion, which is located near the base of the skull and is responsible for controlling the sympathetic nervous system in the head and neck. The symptoms are typically seen on one side of the face, which is why it is also known as a unilateral syndrome.\n\n", "output3": "\n<bot>: Cushing's syndrome is characterized by flushing, warmness, and excessive sweating over the cheeks and pinna of the ear, which is consistent with the symptoms described in the question.\n\n", "output4": "\n<bot>: Fanconi's syndrome is caused by a deficiency of glucose-6-phosphatase, leading to an excess of glucose-6-phosphate in the bloodstream. This can cause flushing, warmth, and perspiration over the cheek and pinna of the ear on the side following the ingestion of highly seasoned food.\n\n"}]